American Association for the Study of Liver Diseases The Liver Meeting 2023

Description Include: 120 videos, size: 65.2 GB Target Audience: gastroenterologists, surgeons, clinical pathologists and radiologists Sample video: contact me for sample video Information: The Liver Meeting 2023, organized by the American Association for the Study of Liver Diseases (AASLD), was held at the Hynes Convention Center in Boston from November 10 to 14, 2023. This meeting brought together clinicians, associates, and scientists from around the world to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.   Topics: Joint Courses & Plenaries AASLD–ASGE Endoscopy Course (Parts 1–4) AASLD–ILTS Transplant Course (Parts 1–4) AASLD–NASPGHAN Pediatric Symposia: Severe Acute Hepatitis; Hepatology Meets Hematology AASLD Japanese Joint Symposium: Cutting-Edge Diagnostics & Treatments in Chronic Liver Disease Clinical Plenary (1–2) • Basic Science Plenary • Transplant Surgery Plenary President’s Welcome • President’s Choice State-of-the-Art: Digitized Medicine Distinguished & State-of-the-Art Lectures: Hans Popper (Gene Therapy), Leon Schiff (Personalized HCC), Thomas E. Starzl (ALD & Transplant) Guidelines, Practice & Workshops Practice Guidelines Workshop: What’s New Clinical Practice SIG • Public Health & Healthcare Delivery SIG: Applied Health Informatics Career Development Workshop • APP-Led Care & Quality Initiatives Surgery & Liver Transplantation Workshop (Parts 1–2) Postgraduate Course: Cirrhosis as a Multisystem Disorder (Parts 1–3) Cirrhosis, Portal Hypertension & ACLF Ascites, AKI & Albumin Cirrhosis & Portal Hypertension: Brain–Gut Insights Portal Hypertension: Varices & Bleeding; Clinical/Experimental SIG ACLF (Sessions 1–2) ACLF: Better Characterization & Treatment The Liver, the Heart & the Vascular System • Vascular Liver Disease: Bench to Bedside Alcohol-Associated Liver Disease (ALD) ALD: Epidemiology, Mortality & Treatment Biomarkers to Building an ALD Research Program Early Liver Transplantation for Severe ALD: Selection, Prognostication & Monitoring ALD Experimental Pathogenesis ALD Debrief • Patient Programming (ALD) Viral Hepatitis & Elimination HBV & HDV: Controversies; New Therapies; Virology/Immunology Hepatitis B SIG: Optimizing Diagnosis & Management for Elimination Hepatitis C: Innovations to Advance Elimination; Patient Programming; White House HCV Plan Hepatitis Elimination: A Global Vision Community Conversation: 2023 WHO HBV Global Guidelines MASLD / MASH & Metabolic Liver Disease Epidemiology & Natural History of MASLD Approved & Available Therapeutics; Therapeutic Pipeline Non-Invasive Tests for MASLD/MASH Novel Biomarkers & Experimental Insights NAFLD Global Variations & Therapeutic Approaches Weight-Inclusive Care & Obesity Management (Multidisciplinary) Steatotic Liver Disease Nomenclature: Implementation MAFLD Patient Programming: Patient-Centered Management Mesenteric Adipose Tissue: Obesity, MASLD & IBD Cholestatic & Autoimmune Liver Disease PBC, PSC & Cholangiocarcinoma: Global Management Updates Cholestatic/Autoimmune SIG: Gut–Liver Axis as a Therapeutic Target Breaking the Chains of Cholestatic Injury: Emerging Treatments Human & Experimental Cholestasis (Basic/Translational) HCC & Liver Cancer Evolving Treatment Paradigms in HCC Liver Cancer SIG: Systemic Therapy from Early to Advanced HCC Novel Diagnostics in Liver Cancer Insights into Hepatocarcinogenesis (Basic Mechanisms) HCC Debrief • Patient Programming (Liver Cancer) Transplantation Current Trends in Liver Transplants Transplant Tracker: Advances & Outcomes (Adults & Children) The Debrief: Liver Transplantation 2023 Liver Transplantation & Surgery SIG Improving Access in Liver Transplantation DILI & Hepatotoxicity Hepatotoxicity SIG Why Are You So Toxic? Mechanisms of Hepatotoxicity Hyman J. Zimmerman Lecture: Acetaminophen—Detection & Treatment (2023) Microbiome, Gut–Liver Axis & Systems Science Gut Microbiota–Liver Crosstalk Bile Acids at the Cross-Road of Gut–Liver & Brain–Liver Axes (Parts 1–4) Decoding the Immunological Tango: Inflammation & Liver Disease Emerging Translational Approaches: Spatial Cellular Heterogeneity in CCA Targeting Genomics for Prognostics & Therapeutics Health Disparities & Social Determinants of Liver Health Pediatrics & Rare Diseases Pediatric Hepatology: Basic Science & Clinical Pediatric Liver Disorders NAFLD SIG (Parts 1–2) Pediatric & Rare Diseases: Patient Programming Debriefs, Editorials & Honors Basic Science Debrief • The Editors’ Cut (Clinical; Basic/Translational) Distinguished Awards & Honors Ceremony The Gritty Ascent to Leadership for Women in GI/Hepatology Implementation Heroes: Masters of Care Delivery in Hepatology Evolving Impact of Hepatology Associates in Liver Care General Hepatology Update